In February 2023 the theme Biobanks and Collections of Health-RI launched a new project entitled: “Dutch biobanking standard: towards harmonized, evidence-based collection, processing and storage of human biomaterials”.
This project comprises the development of a novel Dutch biobanking standard as a fully revised update of the Parelsnoer document that has been used in Dutch UMC’s for clinical biobanking since 2015. The project is led by a 3 member executive committee, that includes professor Dorine Swinkels from the Radboud Biobank.
Garbage in is garbage out. An important prerequisite for obtaining reliable results in biomedical research is the quality of the biomaterials. Low sample quality and variations therein can lead to undesirable post-analytic outcomes, potentially leading to incorrect conclusions and thereby, research waste. Therefore, collection, processing and storage (pre-analysis) of these materials needs to be evidence based to ensure fitness for its future purpose, and needs to be harmonized between biobanks and well documented.
The Parelsnoer standard is a solid guideline for the pre-analysis of biobanks. At the same time this standard needs a thorough revision that is more in line with the recent international developments on sustainability and research with stored biomaterials and as such better serves the needs of high quality and reproducible medical research in the Netherlands.
The project will run until 2026 and aims to develop and implement an evidence-based, fit-for-purpose biobanking standard for various biomaterials for health care research in the Netherlands. The project also aims to create awareness about the importance of pre-analytic standardization within the work field and to stimulate a collective responsibility for pre-analytics . Standards will be developed together with experts on current practice, using a pre-defined Delphi methodology based on scientific evidence for a wide range of human biomaterials commonly used in biomedical research. Implementation of the standards will be carried out with stakeholders representing professionals and users in health care and medical research. The implementation of this biobanking standard shall improve quality and interoperability of biomaterials used for health research innovation and decrease research waste.
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items

First implications of the Radboud Biobank new business model
15 July 2025It was communicated in an earlier news item that the Radboudumc Board of Directors decided to change the Radboud Biobank business model.
read more
Relocation of Radboud Biobank samples to Central Freezing Facility
15 July 2025The Radboud Biobank has now transferred almost all stored samples to the central freezing facility.
read more
Standardized Radboud Biobank procedures for sample handling in Elabgids
15 July 2025The Radboud Biobank is currently preparing to include all standardized Radboud Biobank procedures for sample handling in the eLabgids.
read more
Temporary new location Radboud Biobank Office
15 July 2025The Radboud Biobank office has moved to a temporary new location: route 832 - M325.04.255 (building F).
read more
Europe Biobank Week 2025
15 July 2025The Europe Biobank Week 2025 was a great success for the Dutch biobank community with a strong presence of Dutch biobanking and biomedical research.
read more
National Biobanks & Collections Dag 2025
6 May 2025The second edition of the National Biobanks & Collections Day took place on March 27, 2025, in Nijmegen and attracted 150 participants from all over the Netherlands.
read more